Searched for
DRUG PATENT SYSTEM
Hospitals warn Central Government Health Scheme reimbursement cap may hurt cancer treatmentA major private hospital group warns of a crisis for advanced cancer patients under the Central Government Health Scheme. A reimbursement c...13 May, 2026, 12.43 AM IST- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...10 May, 2026, 08.50 AM IST
- US raises concerns at India’s duties on IP-intensive goods, source code, AI working paperThe US has voiced concerns over India's high customs duties on IP-intensive products and its proposed mandatory blanket license for AI deve...01 May, 2026, 04.39 PM IST
- India is committing selective genocide in healthcareThe recent release of the documentary Fire in the Blood has revived the debate on whether patents block access to life-saving medicines.20 Oct, 2013, 01.06 PM IST
- Inter-ministerial panel to take call on patented drug pricesThe contentious issue of how prices of expensive patented drugs in the country should be controlled would now be decided by an inter-minist...27 Jun, 2013, 06.30 AM IST
- Novartis patent verdict not a problem, other issues pose risks to Indian pharma innovationThe recent Supreme Court judgement against Novartis has reopened old debates on drug patents, affordable healthcare and India as a destinat...16 Apr, 2013, 11.31 AM IST
- Patent drug prices to be set in negotiations with pharma companiesA panel set up to look into the pricing mechanism for patented drugs has said that prices have to be decided after deliberations with manuf...07 Sep, 2012, 04.46 PM IST
- Pharma Department proposes negotiating patent drug rates with firmsThe department is the convener of an inter-ministerial group comprising DIPP and the Health Ministry to modulate a pricing mechanism for pa...02 Sep, 2012, 11.54 AM IST
- Bayer challenges Nexavar generic licence orderBayer has filed an appeal against a patents order, which allowed domestic drug maker Natco Pharma to sell a generic version of the German f...07 May, 2012, 05.08 PM IST
- SC quashes Bayer petition to block Cipla generic drugThe country’s top judicial authority has dismissed German pharmaceutical firm Bayer AG’s attempt to block Indian drug regulator from allowi...02 Dec, 2010, 05.28 AM IST
- HC rejects Bayer plea on Nexavar copycatThe Delhi HC dismissed an appeal by German drugmaker Bayer that sought to stop Cipla from obtaining a marketing approval from the country’s...10 Feb, 2010, 02.16 AM IST
- Govt plans action against costly drugsThe government is laying ground rules for negotiating drug prices with multinational companies to ensure that costly patented drugs are pro...05 May, 2009, 12.23 AM IST
- DCGI pill to check patent misuse a case of overdoseA late and originally hesitant endorser, India, in its overzealousness, is planning moves that even Western countries are have refused to a...06 May, 2008, 04.11 AM IST
- Generic cos may not get nod to sell patented drugsGeneric companies may no longer get marketing approval for copies of those drugs which have got patent in India.26 Apr, 2008, 12.00 AM IST
- Centre weighs Canada model for price regulation of patented drugsMandatory pre-marketing price negotiation for patented drugs, a proposal in the new pharmaceutical policy now being vetted by a group of mi...24 Apr, 2007, 04.40 AM IST
- Copycat drug cos convert, back MNCs on patentsOnce known for trashing patents and denouncing prohibitive pricing by big pharma, Indian generic companies have changed their stance.23 Feb, 2007, 12.56 AM IST
- DIPP's Patent Rules '02 set to stir the hornet's nestThe Department of Industrial Policy & Promotion (DIPP) has finalised the Patent Rules 2002 and referred them to the law ministry for ratifi...25 Dec, 2002, 04.00 AM IST
Load More
